Technical Analysis for PMD - Psychemedics Corporation

Grade Last Price % Change Price Change
grade F 10.38 -2.44% -0.26
PMD closed down 2.44 percent on Friday, May 17, 2019, on approximately normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Very Strong Down Down Down
See historical PMD trend table...

Date Alert Name Type % Chg
New 52 Week Low Weakness 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
1,2,3 Retracement Bearish Bearish Swing Setup -2.44%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -2.44%
Wide Bands Range Expansion -2.44%
Oversold Stochastic Weakness -2.44%
1,2,3 Retracement Bearish Bearish Swing Setup -0.57%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -0.57%
Outside Day Range Expansion -0.57%

Older signals for PMD ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States and internationally. The company's testing methods utilize a patented technology that focuses on liquefying hair and releasing drugs trapped in the hair without destroying the drugs. It provides screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, PCP, and amphetamines; and opiates, including heroin, hydrocodone, hydromorphone, oxycodone, and codeine. The Company's tests provide quantitative information that can indicate the approximate amount of drug ingested, as well as historical data, which shows a pattern of individual drug use over a longer period of time. Psychemedics Corporation offers its services to employers for applicant and employee testing; physicians, treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use; and Fortune 500 companies and small to mid-size corporations. The company was founded in 1985 and is headquartered in Acton, Massachusetts.
Chemical Compounds Organic Compounds Euphoriants Morphinans Opioids Ketones Hydrocodone Testing Services Hydromorphone Oxycodone
Is PMD a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 22.305
52 Week Low 10.08
Average Volume 32,673
200-Day Moving Average 16.9554
50-Day Moving Average 13.1512
20-Day Moving Average 11.1325
10-Day Moving Average 10.437
Average True Range 0.5319
ADX 70.4
+DI 4.6074
-DI 32.034
Chandelier Exit (Long, 3 ATRs ) 12.8343
Chandelier Exit (Short, 3 ATRs ) 11.6757
Upper Bollinger Band 13.2371
Lower Bollinger Band 9.0279
Percent B (%b) 0.32
BandWidth 37.810016
MACD Line -0.9188
MACD Signal Line -1.0138
MACD Histogram 0.095
Fundamentals Value
Market Cap 57 Million
Num Shares 5.49 Million
EPS 1.36
Price-to-Earnings (P/E) Ratio 7.63
Price-to-Sales 2.16
Price-to-Book 5.59
PEG Ratio 0.00
Dividend 0.60
Dividend Yield 5.78%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 11.09
Resistance 3 (R3) 11.06 10.81 10.97
Resistance 2 (R2) 10.81 10.63 10.82 10.93
Resistance 1 (R1) 10.59 10.52 10.47 10.62 10.89
Pivot Point 10.34 10.34 10.27 10.35 10.34
Support 1 (S1) 10.12 10.16 10.00 10.15 9.87
Support 2 (S2) 9.87 10.05 9.88 9.83
Support 3 (S3) 9.65 9.87 9.79
Support 4 (S4) 9.68